ArticleHaematologica2026

FLAG-IDA-venetoclax for high-risk newly diagnosed acute myeloid leukemia: a multicenter real-world study.

Baher Krayem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.